Evaluation of SSD8432 and Ritonavir in Adult Subjects With COVID-19 Clinical Study

NCT05373446 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: SSD8432 300mg
DRUG: SSD8432 750mg
DRUG: SSD8432Placebo

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.